Palisade Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,927
| Closed | -$38K | – | 457 |
|
|
2017
Q2 | $38K | Buy |
3,927
+241
| +7% | +$2.33K | ﹤0.01% | 431 |
|
|
2017
Q1 | $89K | Buy |
3,686
+508
| +16% | +$12.3K | ﹤0.01% | 426 |
|
|
2016
Q4 | $102K | Buy |
3,178
+763
| +32% | +$24.5K | ﹤0.01% | 453 |
|
|
2016
Q3 | $121K | Buy |
2,415
+627
| +35% | +$31.4K | ﹤0.01% | 553 |
|
|
2016
Q2 | $76K | Buy |
1,788
+517
| +41% | +$22K | ﹤0.01% | 524 |
|
|
2016
Q1 | $84K | Hold |
1,271
| – | – | ﹤0.01% | 525 |
|
|
2015
Q4 | $79K | Buy |
+1,271
| New | +$79K | ﹤0.01% | 519 |
|